Cite
HARVARD Citation
Shah, M. et al. (2022). Very high PD‐L1 expression as a prognostic indicator of overall survival among patients with advanced non‐small cell lung cancer receiving anti‐PD‐(L)1 monotherapies in routine practice. Pharmacoepidemiology and drug safety. 31 (10), pp. 1121-1126. [Online].